Embecta EMBC
NASDAQ EMBC
$6.68 +0.26 (+4.05%)
At close: Oct 21, 2026 · 4:00 PM EDT

Embecta (EMBC) Income from Continuing Operations (2020 - 2026)

Updated

Embecta's Income from Continuing Operations came in at $21.1 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), down 53.6% from $45.5 million a year earlier.

Analysis

Embecta (EMBC) Income from Continuing Operations (2020 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, Embecta reported Income from Continuing Operations of $87.5 million, up 4.7% year-over-year; for FY2025 (ended Sep 30, 2025), it was $95.4 million, up 21.8% from FY2024.

  • Income from Continuing Operations carries a five-year compound annual growth rate of -25.9% (FY2020 to FY2025).
  • Going back by fiscal year, Income from Continuing Operations was $78.3 million in FY2024 (+11.2%), $70.4 million in FY2023 (-68.5%), $223.6 million in FY2022 (-46.1%) and $414.8 million in FY2021 (-3.0%).
  • The five-year range for quarterly Income from Continuing Operations is -$17.2 million (fiscal Q4 2022) to $98.8 million (fiscal Q1 2022).
  • Year-over-year, Income from Continuing Operations increased in three of the last five quarters, with growth averaging 72.3%.
  • The fastest year-over-year change in Income from Continuing Operations over five years came in fiscal Q3 2025 (growth of 209.5%), and the weakest in fiscal Q2 2023 (a decline of 82.4%).
  • Business Quant data shows EMBC's Income from Continuing Operations at -$4.1 million (Q2 2026), $44.1 million (Q1 2026) and $26.4 million (Q4 2025) in the three fiscal quarters before Q3 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Thermo Fisher Scientific 257.99 Bn 237.02 Bn 4.88 Bn 1.76 Bn
2 Abbott Laboratories 175.01 Bn 145.44 Bn 7.27 Bn 928.00 Mn
3 Danaher 164.93 Bn 148.74 Bn 3.61 Bn 870.00 Mn
4 Intuitive Surgical 151.84 Bn 131.26 Bn 1.96 Bn 823.20 Mn
5 Medtronic 119.05 Bn 84.30 Bn 6.34 Bn 1.48 Bn
6 Stryker 113.89 Bn 100.00 Bn 4.50 Bn -220.00 Mn
7 Boston Scientific 65.37 Bn 60.13 Bn 3.85 Bn 905.00 Mn
8 Becton Dickinson 53.36 Bn 50.51 Bn 2.32 Bn 451.00 Mn
9 Edwards Lifesciences 50.83 Bn 34.83 Bn 1.35 Bn 241.40 Mn
10 Embecta 390.35 Mn -436.05 Mn 153.30 Mn 21.10 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 21.10 Mn
Mar 31, 2026 -4.10 Mn
Dec 31, 2025 44.10 Mn
Sep 30, 2025 26.40 Mn
Jun 30, 2025 45.50 Mn
Mar 31, 2025 23.50 Mn
Sep 30, 2024 14.60 Mn
Jun 30, 2024 14.70 Mn
Mar 31, 2024 28.90 Mn
Dec 31, 2023 20.10 Mn
Sep 30, 2023 6.00 Mn
Jun 30, 2023 15.20 Mn
Mar 31, 2023 14.00 Mn
Dec 31, 2022 35.20 Mn
Sep 30, 2022 -17.20 Mn
Jun 30, 2022 62.40 Mn
Mar 31, 2022 79.60 Mn
Dec 31, 2021 98.80 Mn
Sep 30, 2021 96.90 Mn
Jun 30, 2021 104.70 Mn
API Access

Embecta Income from Continuing Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-continuing-operations&ticker=EMBC&period=max&api_key=YOUR_API_KEY